N'-(3-(3,4-dimethylphenyl)-4-(2-oxo-2H-chromen-3-yl)thiazol-2(3H)-ylidene)-2-oxo-2H-chromene-3-carbohydrazide

ID: ALA4468410

Chembl Id: CHEMBL4468410

PubChem CID: 155533234

Max Phase: Preclinical

Molecular Formula: C30H21N3O5S

Molecular Weight: 535.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2c(-c3cc4ccccc4oc3=O)cs/c2=N/NC(=O)c2cc3ccccc3oc2=O)cc1C

Standard InChI:  InChI=1S/C30H21N3O5S/c1-17-11-12-21(13-18(17)2)33-24(22-14-19-7-3-5-9-25(19)37-28(22)35)16-39-30(33)32-31-27(34)23-15-20-8-4-6-10-26(20)38-29(23)36/h3-16H,1-2H3,(H,31,34)/b32-30+

Standard InChI Key:  VNENDSDPANZZAV-NHQGMKOOSA-N

Alternative Forms

  1. Parent:

    ALA4468410

    ---

Associated Targets(Human)

NCI-H157 (619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 535.58Molecular Weight (Monoisotopic): 535.1202AlogP: 5.28#Rotatable Bonds: 4
Polar Surface Area: 106.81Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.89CX Basic pKa: CX LogP: 5.71CX LogD: 5.71
Aromatic Rings: 6Heavy Atoms: 39QED Weighted: 0.24Np Likeness Score: -1.14

References

1. Singh H, Singh JV, Bhagat K, Gulati HK, Sanduja M, Kumar N, Kinarivala N, Sharma S..  (2019)  Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.,  27  (16): [PMID:31255497] [10.1016/j.bmc.2019.06.033]

Source